Tech Company Financing Transactions
CytoSorbents Funding Round
Bridge Bank participated in a $5 million funding round for CytoSorbents. The financing round closed on 12/29/2022.
Transaction Overview
Company Name
Announced On
12/29/2022
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Bridge Bank (Lead Investor)
Proceeds Purpose
Non-dilutive debt capital at market favorable terms strengthens the balance sheet and provides additional working capital to fund key clinical and commercial initiatives.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
305 College Road East
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Undisclosed
Website
Email Address
Overview
CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Phillip Chan
Chief Financial Officer
Kathleen Bloch
Chief Operating Officer
Vincent Capponi
Browse more venture capital transactions:
Prev: 12/28/2022: Poly venture capital transaction
Next: 12/30/2022: Avarni venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs